What services does JCC Group provide for pharmaceutical and biologics manufacturers?

JCC Group offers end-to-end regulatory consulting services for pharmaceutical and biologics companies, including 21 CFR Part 211 cGMP compliance, Quality Management System (QMS) design, validation strategy, FDA inspection readiness, supplier qualification, data integrity assessments, and harmonization with ICH international standards (Q7, Q8, Q9, Q10, and Q11). Our consultants partner with clients across the full product lifecycle — from facility start-up and clinical-stage manufacturing through commercial production and post-approval changes.

What types of companies does JCC Group work with?

We support a broad spectrum of clients, including emerging biotech startups, contract manufacturers (CMOs/CDMOs), mid-size pharmaceutical companies, global drug manufacturers, biologics and cell & gene therapy developers, and international manufacturers exporting to the U.S. market. Whether you are launching your first product or managing a multi-site global operation, our services scale to fit your needs.

What is 21 CFR Part 211, and who must comply?

21 CFR Part 211 establishes the FDA's Current Good Manufacturing Practice (cGMP) requirements for finished pharmaceuticals. It applies to any company involved in manufacturing, processing, packaging, labeling, or holding human and veterinary drug products distributed in the United States — including drug substance and drug product manufacturers, contract facilities, and repackagers.

How does JCC Group help companies achieve 21 CFR Part 211 compliance?

We provide comprehensive support including cGMP gap assessments, QMS design and implementation, SOP and documentation development, equipment qualification (IQ/OQ/PQ), process and cleaning validation, quality control laboratory compliance, change control programs, CAPA systems, and mock FDA inspections. Our team builds compliance programs tailored to your operations — not generic templates.

Does JCC Group support biologics manufacturers under 21 CFR Part 211?

Yes. While biologics are also governed by 21 CFR Part 600-series regulations, Part 211 still applies to many aspects of biologic drug product manufacturing. We support biologics manufacturers across monoclonal antibodies, recombinant proteins, vaccines, cell and gene therapies, and biosimilars — addressing both small-molecule and large-molecule complexities.

What are ICH guidelines, and why do they matter?

The International Council for Harmonisation (ICH) develops globally recognized standards for pharmaceutical quality, safety, and efficacy. Compliance with ICH guidelines — especially Q7 (API GMP), Q8 (Pharmaceutical Development), Q9 (Quality Risk Management), Q10 (Pharmaceutical Quality System), and Q11 (Drug Substance Development) — is essential for companies seeking global market access and harmonized regulatory approval across the U.S., EU, Japan, and other ICH regions.

How does JCC Group help companies align with ICH standards?

Our consultants integrate ICH principles into every aspect of our consulting work. We design Pharmaceutical Quality Systems aligned with ICH Q10, implement quality risk management frameworks per ICH Q9, support development activities under Q8/Q11, and ensure API manufacturing aligns with ICH Q7 — enabling clients to meet both FDA expectations and global harmonized requirements simultaneously.

Can JCC Group build a Quality Management System (QMS) from scratch?

Absolutely. We design and implement complete Quality Management Systems for new facilities, startups, and companies transitioning from clinical-stage to commercial manufacturing. Our QMS deliverables include Quality Manuals, SOPs, work instructions, forms, Master Production Records, Batch Production Records, change control systems, and integrated documentation control platforms.

Does JCC Group provide ongoing QMS maintenance and support?

Yes. Beyond initial implementation, we offer long-term advisory services to keep your QMS current with evolving regulations, support periodic management reviews, conduct internal audits, manage CAPA effectiveness checks, and provide regulatory intelligence updates. Many clients engage us as their long-term regulatory partner rather than a one-time consultant.

What happens during a mock FDA inspection conducted by JCC Group?

Our mock inspections replicate real FDA methodology — including facility walkthroughs, document reviews, employee interviews, and front-room/back-room dynamics. We assess your operations against 21 CFR Part 211, your QMS, and applicable ICH standards, then deliver a detailed report with prioritized findings, root cause insights, and clear remediation recommendations.

Can JCC Group help if we received a Form 483 or FDA Warning Letter?

Yes — rapid-response remediation is one of our core specialties. Our team conducts immediate root cause investigations, develops comprehensive CAPA plans, drafts written responses that meet FDA expectations, and manages the remediation process from start to finish. We have helped clients successfully close significant findings and restore compliance under tight deadlines.

Tobacco Products - J&J Consulting Group- FDA Regulatory Compliance

Tobacco Product

Tobacco Product Regulatory Support Services

JJCC Group guides tobacco and vape companies through FDA PMTA applications, product listings, and HPHC compliance efficiently and reliably.

Call for Appoinment

1 (800) 999-7781

99%

Satisfy client

Years of Experience

0 +

Tobacco Compliance

Tobacco Products Regulatory Consulting Services

Developing vape and tobacco products is governed by a complex landscape of laws and regulations aimed at protecting public health and reducing youth access and use. While increased regulatory scrutiny has made market entry more challenging, we believe it should not stand in the way of ethical, innovative entrepreneurs who are committed to delivering responsible products. At JJCC Group, we specialize in guiding clients through every step of the regulatory process. From configuring and submitting PMTA applications to preparing product and ingredient listings, and navigating HPHC requirements, we help you achieve full compliance efficiently and thoroughly. Our mission is to provide unmatched support in meeting federal food and drug compliance standards. We’re committed to ensuring that your product is not only effective and market-ready but also compliant and ethically developed.

PMTA Guidance

Navigating the PMTA Process with Confidence

Submitting a PMTA is a crucial step for FDA authorization. JJCC Group guides you through every requirement, ensuring scientific compliance and maximizing approval chances efficiently.

Regulatory Strategy

We create a tailored regulatory strategy for your product, aligning FDA requirements, and guiding next steps efficiently.

01/

Data Gap Analysis

Our experts review your existing data, identify gaps in research, and provide a roadmap for complete, compliant PMTA submissions.

02/

Scientific Support

We compile and present evidence on product composition and manufacturing processes, including toxicological and HPHC assessments.

03/

Document Preparation

Our team prepares every PMTA section professionally, ensuring technical accuracy and complete electronic submission setup.

04/

Ongoing Regulatory Liaison

We act as your FDA liaison after submission, handling information requests, amendments and all post-submission requirements efficiently.

05/

Post-Authorization Support

If authorized, we continue supporting marketing compliance, and future updates, ensuring regulatory adherence and smooth operations.

06/

Study design and objective setting
Target audience identification and recruitment
Survey development and testing methodology
Data collection, analysis, and interpretation
Compliance with FDA expectations for PMTA submissions

Consumer Insights

Understanding Consumer Perception is Essential to Your Success

Understanding Consumer Perception is Essential to Your Success Consumer perception isn’t just a marketing metric—it’s a driving force behind product success, sales performance, and long-term brand strategy. How your audience views and uses your vape or tobacco product can influence critical business decisions and shape your position in the marketplace.

Conducting a consumer perception study provides valuable insights into your target market. It allows you to see your product through the eyes of potential customers, uncover unfiltered feedback, and make informed, ethical decisions about product development, marketing, and positioning.

Core Services

Your Partner in PMTA Success

At J&J Compliance Consulting Group, we specialize in guiding clients through every stage of the PMTA (Premarket Tobacco Product Application) process with precision, regulatory insight, and a personalized approach. Our goal is to ensure your submission is not only complete, but strategically positioned for FDA approval.

Strategic Assessment & Planning

We begin with a comprehensive initial assessment, diving into your product profile, available data, and prior research.

Expert Documentation & Submission Preparation

We prepare scientific studies, draft reports, assemble PMTA modules, ensuring accurate, and compelling submission.

Post-Submission Support & Project Completion

We provide post-submission support, track applications, respond to FDA inquiries, ensuring successful PMTA approval.

Regulatory Planning

JJCC group ensures strategic planning for full regulatory compliance and efficient approvals.

Data Analysis

Experts carefully review all product data, identifying critical gaps for complete PMTA submissions.

Technical Support

We provide scientific evidence, hphc assessments, and accurate technical documentation.

Submission Management

Team prepares, reviews, and submits all PMTA sections accurately and on-time.

Complete Guide to Vape and Tobacco Compliance Standards

Regulatory Guidance

Harmful and Potentially Harmful Constituents (HPHCs) Guidance

The FDA requires that all vape and tobacco manufacturers report the exact levels of harmful and potentially harmful ingredients found in their products. These ingredients may include chemicals in your product or your product’s byproduct (such as smoke) that could cause significant harm to people that use your product.

Best Compliance with 5 Star

99% Happy Clients

Testimonial

What our clients say about JJCC Group

Our clients trust JJCC Group for expert MoCRA compliance guidance, efficient FDA registration, and accurate cosmetic regulatory support worldwide.

Professional guidance and clear communication from JJCC Group made our PMTA process completely stress-free.

Sarah Bennett OWNER

Thanks to JJCC Group, our vape product fully complied with HPHC reporting and labeling requirements.

Bts Ashik OWNER

JJCC provided detailed analysis and guidance, making our PMTA submission complete, accurate, and FDA-ready.

Shadin De Manager

Faqs

Frequently Asked Questions

JJCC Group answers your most common queries about PMTA submissions, HPHC reporting, and tobacco product compliance. Learn how our experts guide you through regulatory processes, consumer perception studies, and FDA requirements. We help ensure your products meet all federal standards efficiently, reduce risks, and achieve successful market authorization.

Why Do I Need a Consumer Perception Study for a tobacco product?

To obtain a marketing order for a tobacco product, the FDA requires a consumer perception study as a part of the statutory requirement of the Premarket Tobacco Product Application (PMTA). Besides being a prerequisite for the marketing of your tobacco or vape product and a requirement of the Premarket of Tobacco Product (PMTA), a consumer perception study will help you and your organization get a crystal-clear vision of the way the public consumes products like yours and perceives your product.

What is a Consumer Perception Study?

A consumer perception study is a methodical evaluation designed to collect knowledge of your consumer’s perception of the risks associated with tobacco and vape products. This evaluation addresses peoples’ interest in and intentions to use a tobacco or vape product. It even includes populations of non-users of tobacco products (including vulnerable populations such as youth and young adults).

The consumer perception study consists of qualitative and quantitative research conducted with various groups of consumers, including current and former adult tobacco users, young adult tobacco users and adolescents who either use tobacco or are susceptible to tobacco use initiation. Your consumer perception study should include significant scientific evidence supporting the fact that the marketing of your tobacco or vape product doesn’t disrupt the overall protection of public health (AHHP).

Description of a Clinical Study for a Tobacco or Vape Product

The clinical study of a tobacco product should include an evaluation of the pharmacokinetics of nicotine in an in-vitro study. Your study should consider the addictiveness and abuse potential of your new product and the users’ exposure to nicotine while using your product.

In this study of tobacco products, J&J CC Group evaluates tobacco use behavior among multiple individuals, placing emphasis on recording and understanding the likelihood of initiation and cessation of your product among smokers and non-smokers.

What Happens During the Tobacco Study?

In your consumer perception study, JJCC Group will gather tobacco product use patterns into a topography study, thus allowing us to demonstrate how individual users consume your product (such as the number of puffs one takes, one’s puff duration, one’s puff intensity, and overall duration of one’s use). The consumer perception study also serves to record the frequency with which consumers use the product and the trends by which users consume the product over time.

At JJCC Group, our scientists and researchers work with CRO and IRB licensing facilities to design and execute all the protocols for the clinical and non-clinical studies that meet the FDA requirement as described in the PMTA guidance.

Allow JJCC Group’s vape and tobacco regulatory compliance consultants to assist you in the creation and implementation of your consumer perception study. Our strategic methods will expedite your FDA pre-marketing approval process and increase your likelihood of attaining PMTA approval from the FDA. We are ready and willing to answer any and all questions you have today. Be sure to call us at (800) 988-1712
to speak to one of our friendly consultants.